Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Buy TRDA Stock  Free TRDA Stock Alerts

Entrada Therapeutics (TRDA) SEC Filings & 10K Form

Entrada Therapeutics logo
$8.71 0.00 (0.00%)
Closing price 04/23/2025 04:00 PM Eastern
Extended Trading
$8.71 0.00 (0.00%)
As of 04/23/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Entrada Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/04/2025
3:34 PM		Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
6:08 AM		Entrada Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2025
6:06 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
3:32 PM		Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:02 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:07 AM		Entrada Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:16 AM		Entrada Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2025
6:02 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
2:47 PM		Entrada Therapeutics (Subject)
ROCHE FINANCE LTD (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:25 AM		Entrada Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G
02/03/2025
6:05 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
4:00 PM		Entrada Therapeutics (Issuer)
EVNIN LUKE (Reporting)
Foley Todd (Reporting)
GADICKE ANSBERT (Reporting)
MPM Asset Management Investors BV2014 LLC (Reporting)
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC (Reporting)
MPM BioVentures 2014 GP LLC (Reporting)
MPM BioVentures 2014 LLC (Reporting)
MPM BioVentures 2014, L.P. (Reporting)
MPM BIOVENTURES 2018 , L.P. (0001729504) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:00 PM		Entrada Therapeutics (Issuer)
MPM BioVentures 2018 GP LLC (Reporting)
MPM BioVentures 2018 LLC (Reporting)
MPM BIOVENTURES 2018, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:24 PM		Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:26 PM		Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:47 PM		Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:49 PM		Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:06 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:12 AM		Entrada Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
3:31 PM		Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:25 PM		Entrada Therapeutics (Subject)
Sethuraman Natarajan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
3:32 PM		Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:32 PM		Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:33 PM		Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:34 PM		Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
3:27 PM		Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
3:19 PM		Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
5:46 PM		Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
5:49 PM		Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
5:47 PM		Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
5:48 PM		Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:33 PM		Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:25 PM		Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
6:05 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:14 AM		Entrada Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/16/2024
3:42 PM		Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:43 PM		Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM		Doshi Dipal (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:34 PM		Entrada Therapeutics (Subject)
Sethuraman Natarajan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
3:34 PM		Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:18 PM		Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The Exact July Date the AI Correction Will End? (Ad)

AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one date in July could spark the next boom. It involves Elon Musk, a hidden supplier, and a “guaranteed” trigger event. You don’t want to miss this.

See the July 23 prediction that could reset AI stocks
06/26/2024
3:53 PM		Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:54 PM		BAKER BROS. ADVISORS LP (Filed by)
Entrada Therapeutics (Subject)
Form SC 13D/A
06/24/2024
6:22 AM		Entrada Therapeutics (Filer)
Form 424B5
06/24/2024
6:25 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:07 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:36 PM		Entrada Therapeutics (Issuer)
Thistle Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:38 PM		Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:39 PM		Entrada Therapeutics (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:34 PM		Entrada Therapeutics (Issuer)
Zeiher Bernhardt G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:32 PM		Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:33 PM		Chapman Gina (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:31 PM		Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:21 PM		Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:26 PM		Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:33 PM		Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:35 PM		Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:04 AM		Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:10 AM		Entrada Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2024
3:17 PM		Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2024
8:11 AM		Entrada Therapeutics (Filer)
Form DEF 14A
04/29/2024
8:13 AM		Entrada Therapeutics (Filer)
Form DEFA14A
04/29/2024
8:14 AM		Entrada Therapeutics (Filer)
Form ARS
04/25/2024
3:30 PM		Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2024
3:20 PM		Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2024
3:18 PM		Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TRDA) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
The Exact July Date the AI Correction Will End?
AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...
Brownstone Research | Sponsored
Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...
Colonial Metals | Sponsored
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...
Stansberry Research | Sponsored
Trump’s treachery
Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...
Porter & Company | Sponsored